Latest AI and machine learning research in breast cancer for healthcare professionals.
PURPOSE: Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis. O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation is a critical biomarker for guiding chemotherapy decisions, yet current testing requires invasive tissue sampling. This study aimed to systematically evaluate the diagnostic accuracy of artificial intelligence (AI) models using MRI for non-invasive predic...
BACKGROUND: Lung adenocarcinoma (LUAD) is a predominant contributor to cancer‑related mortality globally. Lung‑associated fibroblasts (LAFs) are intricately linked to tumorigenesis and the tumor microenvironment (TME), but their heterogeneity and prognostic relevance in LUAD remain incompletely understood. This study aimed to systematically characterize LAF subsets across the spectrum of pulmonary...
BACKGROUND: Pancreatic cancer requires nuanced, multidisciplinary treatment planning typically conducted within tumor boards. While Large Language Mod...
Risk stratification across the three main clinical subsets of malignant peripheral nerve sheath tumor (MPNST), neurofibromatosis type I (NF1-related),...
Programmed death-ligand 1 (PD-L1) plays a central role in immune regulation in esophageal squamous cell carcinoma (ESCC) and has been widely used as a...
BACKGROUND AND OBJECTIVES: Stereotactic body radiotherapy (SBRT) has emerged as an effective treatment modality for spinal metastases. However, high-p...
BACKGROUND: Histological typing of carcinomas is crucial considering the varying progression, prognosis, and treatment efficacy. Clear cell and mucino...
Rapid assessment of chemotherapeutic response is essential for precision oncology but remains hindered by tumor heterogeneity and complex biological m...
BACKGROUND: International guidelines recommend 5FU/LV, Nal-IRI + 5FU/LV, FOLFIRI, FOLFOX, or (m)FOLFIRINOX as second-line (2 L) chemotherapy for patie...
177Lu-PSMA-targeted radioligand therapy (TRT) represents a major advance in managing metastatic castration-resistant prostate cancer (mCRPC), exploiti...
Antibody-drug conjugates (ADCs) are a leading area of targeted cancer therapeutics, typically combining a tumour-associated antigen-specific antibody ...
Whole-body MRI (WB-MRI) has evolved over the past 2 decades as a noninvasive imaging technique for detecting distant metastases in prostate cancer. Si...
Pancreatic cancer is highly aggressive with poor outcomes; current artificial intelligence (AI) prognostic models often lack interpretability and unde...
Accurate classification of disease subtypes is a fundamental requirement of precision medicine especially for complex and heterogeneous conditions suc...
OBJECTIVE: To define oncologic outcomes in Veterans in the modern era using a multi-institutional cohort designed to support development and validatio...
PURPOSE: To introduce a hybrid quantum-classical machine learning approach and validate its feasibility and accuracy for pretreatment radiation-induce...
BACKGROUND: Clinical competency-based education (CBE) has emerged as a critical strategy to enhance workforce readiness in radiation sciences. Despite...
Accurate assessment of Human Epidermal Growth Factor Receptor 2 (HER2) immunohistochemistry (IHC) expression, particularly the precise identification ...
This review highlights our group's systematic approach to integrating molecular docking, pharmacophore modeling, and machine learning methodologies fo...
OBJECTIVE: Conventional image-based models for radionuclide therapy dosimetry are typically radionuclide-specific and rely on nuclear medicine (NM) im...